Amgen
New Phase 3 data show the possible benefits of Aranesp for cancer-related anemia
Published in Drug Law Weekly, January 3rd, 2006
The study revealed that Aranesp increased and maintained patient hemoglobin levels to the target level of {{>=}}11 g/dL and reduced the need for red blood cell transfusions by almost half compared to placebo. The data were presented at the American Society of Hematology (ASH) 47th Annual Meeting and Exposition.
"These results on every-3-week dosing of Aranesp are encouraging," said Kerry Taylor, MD, Mater...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-01-03)
More Articles from Drug Law Weekly
- American Environmental Products, Inc.
Lighting technology patented for the treatment of seasonal affective disorder - Cephalon, Inc.
Research agreements signed for development of potential psoriasis, restenosis treatment - Collaborations
Alliance formed with Allscripts to provide electronic prescribing solutions - Columbia University
Patients with Alzheimer disease receive less treatment for breast cancer than do other female Medicare beneficiaries - Eisai Co., Ltd.
Legal action begins over Aricept ANDA filing - EntreMed, Inc.
Pharmaceutical company receives composition of matter patent claims for 2ME2 - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
